David J. Nutt

Dr Shipman’s last legacy: e-surveillance of the medical profession
J Psychopharmacol 2005 19: 441. [PDF] [References]  

Conflict of interest statement
J Psychopharmacol 2005 19: 442. [PDF]  

Briony J. Catlow and Cheryl L. Kirstein

Heightened cocaine-induced locomotor activity in adolescent compared to adult female rats
J Psychopharmacol 2005 19: 443-447. [Abstract] [PDF] [References]  

Marina Perfumi, Laura Mattioli, Marino Cucculelli, and Maurizio Massi

Reduction of ethanol intake by chronic treatment with Hypericum perforatum, alone or combined with naltrexone in rats
J Psychopharmacol 2005 19: 448-454. [Abstract] [PDF] [References]  

N. G. Muggleton, A. J. Smith, E. A. M. Scott, S. J. Wilson, and P. C. Pearce

A long-term study of the effects of diazinon on sleep, the electrocorticogram and cognitive behaviour in common marmosets
J Psychopharmacol 2005 19: 455-466. [Abstract] [PDF] [References]  

Amani E. Khalifa

Neural monoaminergic mediation of the effect of St. John’s wort extract on prepulse inhibition of the acoustic startle response in rats
J Psychopharmacol 2005 19: 467-472. [Abstract] [PDF] [References]  

Deborah Layton, Scott Harris, Lynda V. Wilton, and Saad A. W. Shakir

Comparison of incidence rates of cerebrovascular accidents and transient ischaemic attacks in observational cohort studies of patients prescribed risperidone, quetiapine or olanzapine in general practice in England including patients with dementia
J Psychopharmacol 2005 19: 473-482. [Abstract] [PDF] [References]  

Francesco Gambi, Domenico De Berardis, Daniela Campanella, Alessandro Carano, Gianna Sepede, Gabriele Salini, Daniela Mezzano, Alessandra Cicconetti, Laura Penna, Rosa Maria Salerno, and Filippo Maria Ferro

Mirtazapine treatment of Generalized Anxiety Disorder: a fixed dose, open label study
J Psychopharmacol 2005 19: 483-487. [Abstract] [PDF] [References]  

G. J. E Schmitt, E. M. Meisenzahl, T. Frodl, C. La Fougère, K. Hahn, H- J. Möller, and S. Dresel

The striatal dopamine transporter in first-episode, drug-naive schizophrenic patients: evaluation by the new SPECT-ligand[99mTc]TRODAT-1
J Psychopharmacol 2005 19: 488-493. [Abstract] [PDF] [References]  

Stefano Zanone Poma, Stefano Milleri, Lisa Squassante, Gianluca Nucci, Massimo Bani, Giulia I. Perini, and Emilio Merlo-Pich

Characterization of a 7% carbon dioxide (CO2) inhalation paradigm to evoke anxiety symptoms in healthy subjects
J Psychopharmacol 2005 19: 494-503. [Abstract] [PDF] [References]  

Alex Gamma, Daniel Brandeis, Ruven Brandeis, and Franz X. Vollenweider

The P3 in ‘ecstasy’ polydrug users during response inhibition and execution
J Psychopharmacol 2005 19: 504-512. [Abstract] [PDF] [References]  

C. Mohr, P. S. Sándor, T. Landis, M. Fathi, and P. Brugger

Blinking and schizotypal thinking
J Psychopharmacol 2005 19: 513-520. [Abstract] [PDF] [References]  

O. Dinca, M. Paul, and N. J. Spencer

Systematic review of randomized controlled trials of atypical antipsychotics and selective serotonin reuptake inhibitors for behavioural problems associated with pervasive developmental disorders
J Psychopharmacol 2005 19: 521-532. [Abstract] [PDF] [References]  

Valérie J. Fedorowicz and Eric Fombonne

Metabolic side effects of atypical antipsychotics in children: a literature review
J Psychopharmacol 2005 19: 533-550. [Abstract] [PDF] [References]  

Wei Zhang, Kathryn M. Connor, and Jonathan R. T. Davidson

Levetiracetam in social phobia: a placebo controlled pilot study
J Psychopharmacol 2005 19: 551-553. [Abstract] [PDF] [References]  

P. M. Haddad, B. R. Pal, P. Clarke, A. Wieck, and S. Sridhiran

Neonatal symptoms following maternal paroxetine treatment: Serotonin toxicity or paroxetine discontinuation syndrome?
J Psychopharmacol 2005 19: 554-557. [Abstract] [PDF] [References]  

Mark Taylor

Book Review: Treating Schizophrenia in the Prodromal Phase
J Psychopharmacol 2005 19: 558-559. [PDF]  

Graham Parton

Book Review: Treating Depression Effectively: Applying Clinical Guidelines
J Psychopharmacol 2005 19: 558. [PDF]  

Daniel J Smith

Book Review: Seminars in Clinical Psychopharmacology
J Psychopharmacol 2005 19: 559. [PDF]  

Julia Clark

Book Review: Integrating Psychotherapy and Pharmacotherapy - Dissolving the Mind-Brain Barrier
J Psychopharmacol 2005 19: 560. [PDF]  

P. L. Johnson, J. H. Hollis, R. Moratalla, S. L. Lightman, and C. A. Lowry

Acute hypercarbic gas exposure reveals functionally distinct subpopulations of serotonergic neurons in rates
J Psychopharmacol 2005 19: 561. [PDF]  

To see an article, click its [PDF] link. To add articles to your marked citations, check the boxes to the left of the titles you want, and click the 'Add to Marked Citations' button. To see one abstract at a time, click its [Abstract] link.